14.03.2016 • NewsoperationsManufacturingsmolders

Ad Smolders Joins Reverdia As Operations Director

Reverdia has announced that Ad Smolders has joined the company as Operations...
Reverdia has announced that Ad Smolders has joined the company as Operations Director. Reverdia is a joint venture between DSM and Roquette and produces, markets and licenses bio-based succinic acid under the brand name Biosuccinium.

Reverdia has announced that Ad Smolders has joined the company as Operations Director. Reverdia is a joint venture between DSM and Roquette and produces, markets and licenses bio-based succinic acid under the brand name Biosuccinium.

Smolders previously worked at DSM for seventeen years in various international technology and manufacturing assignments. More recently, he has overseen an extensive number of operations projects, including the optimization of yeast plants, as a consultant and interim manager.

Marcel Lubben, Reverdia’s President said, “With his considerable experience in manufacturing and process improvement, Ad Smolders will lead Reverdia’s operations to the next stage of growth.  His leadership in manufacturing excellence will further bolster our low pH yeast technology. This will benefit both our clients out of Cassano and also our partners and licensees for future Biosuccinium plants.”   
 
 

Company

Reverdia

Urmonderbaan 20H
6167 RD Geleen

Company contact







Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.